These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 38659243)

  • 21. Molecular epidemiology and drug resistant mechanism in carbapenem-resistant Klebsiella pneumoniae isolated from pediatric patients in Shanghai, China.
    Zhang X; Chen D; Xu G; Huang W; Wang X
    PLoS One; 2018; 13(3):e0194000. PubMed ID: 29558475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a quadruple qRT-PCR assay for simultaneous identification of hypervirulent and carbapenem-resistant
    Xu Z; Li B; Jiang Y; Huang J; Su L; Wu W; Pang Q; Li Z; Zhang J; Li X; Wang J; Cen F; Peng L; Liang J; Wang F; Liu C; Shen C; Liu Y; Yang Y
    Microbiol Spectr; 2024 Jan; 12(1):e0071923. PubMed ID: 38059628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for infections due to carbapenem-resistant Klebsiella pneumoniae after open heart surgery.
    Salsano A; Giacobbe DR; Sportelli E; Olivieri GM; Brega C; Di Biase C; Coppo E; Marchese A; Del Bono V; Viscoli C; Santini F
    Interact Cardiovasc Thorac Surg; 2016 Nov; 23(5):762-768. PubMed ID: 27371609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment.
    Gaibani P; Campoli C; Lewis RE; Volpe SL; Scaltriti E; Giannella M; Pongolini S; Berlingeri A; Cristini F; Bartoletti M; Tedeschi S; Ambretti S
    J Antimicrob Chemother; 2018 Jun; 73(6):1525-1529. PubMed ID: 29566151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Occurrence of carbapenem-resistant hypervirulent Klebsiella pneumoniae in oysters in Egypt: a significant public health issue.
    Mohammed R; Nader SM; Hamza DA; Sabry MA
    Ann Clin Microbiol Antimicrob; 2024 Jun; 23(1):53. PubMed ID: 38886796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral gentamicin therapy for Carbapenem-resistant Klebsiella pneumoniae gut colonization in hematologic patients: a single center experience.
    Lambelet P; Tascini C; Fortunato S; Stefanelli A; Simonetti F; Vettori C; Leonildi A; Menichetti F
    New Microbiol; 2017 Jul; 40(3):161-164. PubMed ID: 28513809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular insights of Carbapenem resistance Klebsiella pneumoniae isolates with focus on multidrug resistance from clinical samples.
    Indrajith S; Mukhopadhyay AK; Chowdhury G; Farraj DAA; Alkufeidy RM; Natesan S; Meghanathan V; Gopal S; Muthupandian S
    J Infect Public Health; 2021 Jan; 14(1):131-138. PubMed ID: 33234410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Two Antibiotic Therapies on Clinical Outcome and Gut Microbiota Profile in Liver Transplant Paediatric Candidates Colonized by Carbapenem-Resistant
    Cardile S; Del Chierico F; Candusso M; Reddel S; Bernaschi P; Pietrobattista A; Spada M; Torre G; Putignani L
    Front Cell Infect Microbiol; 2021; 11():730904. PubMed ID: 34970503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-existence of NDM-1 and OXA-48 genes in Carbapenem Resistant
    Ahmed El-Domany R; El-Banna T; Sonbol F; Abu-Sayedahmed SH
    Afr Health Sci; 2021 Jun; 21(2):489-496. PubMed ID: 34795700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular characterization of carbapenem-resistant and virulent plasmids in
    Yang Y; Yang Y; Chen G; Lin M; Chen Y; He R; Galvão KN; El-Gawad El-Sayed Ahmed MA; Roberts AP; Wu Y; Zhong LL; Liang X; Qin M; Ding X; Deng W; Huang S; Li HY; Dai M; Chen DQ; Zhang L; Liao K; Xia Y; Tian GB
    Emerg Microbes Infect; 2021 Dec; 10(1):700-709. PubMed ID: 33739229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology, management, and outcome of carbapenem-resistant Klebsiella pneumoniae bloodstream infections in hospitals within the same endemic metropolitan area.
    Cristina ML; Alicino C; Sartini M; Faccio V; Spagnolo AM; Bono VD; Cassola G; De Mite AM; Crisalli MP; Ottria G; Schinca E; Pinto GL; Bottaro LC; Viscoli C; Orsi A; Giacobbe DR; Icardi G;
    J Infect Public Health; 2018; 11(2):171-177. PubMed ID: 28668656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient-Derived Antibody Data Yields Development of Broadly Cross-Protective Monoclonal Antibody against ST258 Carbapenem-Resistant
    Banerjee K; Motley MP; Boniche-Alfaro C; Bhattacharya S; Shah R; Ardizzone A; Fries BC
    Microbiol Spectr; 2022 Aug; 10(4):e0176022. PubMed ID: 35862974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A plasmid locus associated with Klebsiella clinical infections encodes a microbiome-dependent gut fitness factor.
    Vornhagen J; Bassis CM; Ramakrishnan S; Hein R; Mason S; Bergman Y; Sunshine N; Fan Y; Holmes CL; Timp W; Schatz MC; Young VB; Simner PJ; Bachman MA
    PLoS Pathog; 2021 Apr; 17(4):e1009537. PubMed ID: 33930099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of predictive scores in the management of patients with carbapenem-resistant Klebsiella pneumoniae infection.
    Giannella M; Pascale R; Gutiérrez-Gutiérrez B; Cano A; Viale P
    Expert Rev Anti Infect Ther; 2019 Apr; 17(4):265-273. PubMed ID: 30876375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emergence of ceftazidime-avibactam resistance due to a novel blaKPC-2 mutation during treatment of carbapenem-resistant Klebsiella pneumoniae infections.
    Liao Q; Deng J; Feng Y; Zhang W; Wu S; Liu Y; Che H; Xie Y
    J Infect Public Health; 2022 May; 15(5):545-549. PubMed ID: 35461077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae of Sequence Type 36.
    Feng Y; Lu Y; Yao Z; Zong Z
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New options for bloodstream infections caused by colistin- or ceftazidime/avibactam-resistant Klebsiella pneumoniae.
    Yu W; Luo Q; Shen P; Chen Y; Xu H; Xiao Y; Qiu Y
    Int J Antimicrob Agents; 2021 Dec; 58(6):106458. PubMed ID: 34706255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical use of tigecycline may contribute to the widespread dissemination of carbapenem-resistant hypervirulent
    Xie M; Ye L; Chen K; Xu Q; Yang C; Chen X; Chan EW; Li F; Chen S
    Emerg Microbes Infect; 2024 Dec; 13(1):2306957. PubMed ID: 38240375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adaptive attenuation of virulence in hypervirulent carbapenem-resistant
    Teng G; Zhang M; Fu Y; Yang X; Kang Y; Qin Q; Jin Y; Huang M; Xu Y
    mSystems; 2024 Jun; 9(6):e0136323. PubMed ID: 38752758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In-vivo loss of carbapenem resistance by extensively drug-resistant Klebsiella pneumoniae during treatment via porin expression modification.
    Bialek-Davenet S; Mayer N; Vergalli J; Duprilot M; Brisse S; Pagès JM; Nicolas-Chanoine MH
    Sci Rep; 2017 Jul; 7(1):6722. PubMed ID: 28751669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.